Dilemmas in the Management of an Infant with Neuroblastoma Metastasized to the Muscles

The risk stratification of infants with metastatic neuroblastoma (NB) has evolved over time from stage 4/M or IVs/4S/MS/Ms according to various staging systems. Despite these developments for some genetic aberrations, the prognostic value and the impact of soft tissue metastases in infants are not f...

Full description

Bibliographic Details
Main Authors: Jaques van Heerden, Machiel van den Akker, Joris Verlooy, Nadine Van Roy, Geneviève Laureys, Koen Norga
Format: Article
Language:English
Published: Karger Publishers 2023-07-01
Series:Case Reports in Oncology
Subjects:
Online Access:https://beta.karger.com/Article/FullText/531433
_version_ 1797737628504686592
author Jaques van Heerden
Machiel van den Akker
Joris Verlooy
Nadine Van Roy
Geneviève Laureys
Koen Norga
author_facet Jaques van Heerden
Machiel van den Akker
Joris Verlooy
Nadine Van Roy
Geneviève Laureys
Koen Norga
author_sort Jaques van Heerden
collection DOAJ
description The risk stratification of infants with metastatic neuroblastoma (NB) has evolved over time from stage 4/M or IVs/4S/MS/Ms according to various staging systems. Despite these developments for some genetic aberrations, the prognostic value and the impact of soft tissue metastases in infants are not fully understood, nor well described in the different classification systems, hampering the definitions to uniformly treat patients and predict prognosis. A literature review on staging of infants with M/MS disease was performed at the occasion of the diagnosis of NB in an 8-month-old boy who presented with atypical metastatic sites in soft tissue and an aberrant tumor biology. The definitions of stage 4/4S/4s/M/MS/Ms were evaluated and compared to enable tumor risk stratification and inform management. International NB groups use different criteria for defining stage of infants with metastasized NB, resulting in differences in management. Limited literature is available on soft tissue metastases, especially muscular metastases, and is poorly incorporated into management guidelines mainly due to the lack of data. The uncertain prognosis of rare genetic aberrancies may add to the difficulties in treatment decisions. In some rare cases of NB in infants, the international treatment classification is not sufficient for staging and treatment decisions. Based on tumor progression, biology of unknown significance and a lack of evidence to classify a child under 12 months with NB and multiple muscular metastases, the patient was treated as stage 4/M and intermediate-risk protocols with a favorable outcome.
first_indexed 2024-03-12T13:31:11Z
format Article
id doaj.art-1f18a9f4221642848a45fb72448be1ad
institution Directory Open Access Journal
issn 1662-6575
language English
last_indexed 2024-03-12T13:31:11Z
publishDate 2023-07-01
publisher Karger Publishers
record_format Article
series Case Reports in Oncology
spelling doaj.art-1f18a9f4221642848a45fb72448be1ad2023-08-24T09:41:54ZengKarger PublishersCase Reports in Oncology1662-65752023-07-0116155256110.1159/000531433531433Dilemmas in the Management of an Infant with Neuroblastoma Metastasized to the MusclesJaques van Heerden0https://orcid.org/0000-0002-4502-1169Machiel van den Akker1Joris Verlooy2Nadine Van Roy3Geneviève Laureys4Koen Norga5Department of Pediatric Haematology and Oncology, Antwerp University Hospital, Antwerp, BelgiumDepartment of Pediatric Haematology and Oncology, Antwerp University Hospital, Antwerp, BelgiumDepartment of Pediatric Haematology and Oncology, Antwerp University Hospital, Antwerp, BelgiumCancer Research Institute Ghent (CRIG), Ghent University, Ghent, BelgiumCancer Research Institute Ghent (CRIG), Ghent University, Ghent, BelgiumDepartment of Pediatric Haematology and Oncology, Antwerp University Hospital, Antwerp, BelgiumThe risk stratification of infants with metastatic neuroblastoma (NB) has evolved over time from stage 4/M or IVs/4S/MS/Ms according to various staging systems. Despite these developments for some genetic aberrations, the prognostic value and the impact of soft tissue metastases in infants are not fully understood, nor well described in the different classification systems, hampering the definitions to uniformly treat patients and predict prognosis. A literature review on staging of infants with M/MS disease was performed at the occasion of the diagnosis of NB in an 8-month-old boy who presented with atypical metastatic sites in soft tissue and an aberrant tumor biology. The definitions of stage 4/4S/4s/M/MS/Ms were evaluated and compared to enable tumor risk stratification and inform management. International NB groups use different criteria for defining stage of infants with metastasized NB, resulting in differences in management. Limited literature is available on soft tissue metastases, especially muscular metastases, and is poorly incorporated into management guidelines mainly due to the lack of data. The uncertain prognosis of rare genetic aberrancies may add to the difficulties in treatment decisions. In some rare cases of NB in infants, the international treatment classification is not sufficient for staging and treatment decisions. Based on tumor progression, biology of unknown significance and a lack of evidence to classify a child under 12 months with NB and multiple muscular metastases, the patient was treated as stage 4/M and intermediate-risk protocols with a favorable outcome.https://beta.karger.com/Article/FullText/531433neuroblastomasoft tissue metastasisrisk stratificationinfantcase report
spellingShingle Jaques van Heerden
Machiel van den Akker
Joris Verlooy
Nadine Van Roy
Geneviève Laureys
Koen Norga
Dilemmas in the Management of an Infant with Neuroblastoma Metastasized to the Muscles
Case Reports in Oncology
neuroblastoma
soft tissue metastasis
risk stratification
infant
case report
title Dilemmas in the Management of an Infant with Neuroblastoma Metastasized to the Muscles
title_full Dilemmas in the Management of an Infant with Neuroblastoma Metastasized to the Muscles
title_fullStr Dilemmas in the Management of an Infant with Neuroblastoma Metastasized to the Muscles
title_full_unstemmed Dilemmas in the Management of an Infant with Neuroblastoma Metastasized to the Muscles
title_short Dilemmas in the Management of an Infant with Neuroblastoma Metastasized to the Muscles
title_sort dilemmas in the management of an infant with neuroblastoma metastasized to the muscles
topic neuroblastoma
soft tissue metastasis
risk stratification
infant
case report
url https://beta.karger.com/Article/FullText/531433
work_keys_str_mv AT jaquesvanheerden dilemmasinthemanagementofaninfantwithneuroblastomametastasizedtothemuscles
AT machielvandenakker dilemmasinthemanagementofaninfantwithneuroblastomametastasizedtothemuscles
AT jorisverlooy dilemmasinthemanagementofaninfantwithneuroblastomametastasizedtothemuscles
AT nadinevanroy dilemmasinthemanagementofaninfantwithneuroblastomametastasizedtothemuscles
AT genevievelaureys dilemmasinthemanagementofaninfantwithneuroblastomametastasizedtothemuscles
AT koennorga dilemmasinthemanagementofaninfantwithneuroblastomametastasizedtothemuscles